Interaction between estrogen receptor alpha, ionizing radiation and (anti-) estrogens in breast cancer cells.

2005-10

PURPOSE: Estrogen receptor alpha (ERalpha) plays a major role in breast cancer development. It acts as ligand-inducible transcription factor which determines growth, survival and differentiation of breast cancer cells. The aim of this study is to evaluate the potential interference between radiotherapy and estrogen receptor responsiveness. Materials and methods. The effect of ionizing radiation was assessed on the estrogen receptor alpha status, growth (proliferation and apoptosis) and sensitivity of MCF-7 breast cancer cells to estrogenic (17beta-estradiol (E2)), selective estrogen receptor modulator (SERM) and anti-estrogenic compounds. Results. We have observed a ligand-independent decrease in ERalpha expression after radiation, resulting from a specific reduction in mRNA level and protein synthesis. This ERalpha disappearance occurred 72 h post-irradiation at 8 Gy and decreased the transcriptional activity in ERalpha of these cells. On the other hand, E2 impedes the growth inhibitory effects (essentially on proliferation) of ionizing radiation in MCF-7 cells, which potentially decreases radiosensitivity of these cells. This effect was totally blocked by SERM and anti-estrogenic treatments. Moreover, this growth effect of concurrent anti-estrogenic drugs and ionizing radiation appeared to be strongly synergistic. CONCLUSIONS: This study may increase general comprehension of ERalpha modulation by radiotherapy and improve adjuvant therapeutic approaches based on co-administration of radiation and endocrine therapy.
Evaluation Studies
Journal Article
Research Support, Non-U.S. Gov't
info:eu-repo/semantics/published

Sciences bio-médicales et agricoles; Analysis of Variance; Antineoplastic Agents, Hormonal -- pharmacology; Apoptosis -- radiation effects; Breast Neoplasms -- drug therapy; Breast Neoplasms -- radiotherapy; Cell Cycle -- radiation effects; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Estradiol -- pharmacology; Estrogen Antagonists -- pharmacology; Estrogen Receptor alpha -- biosynthesis; Estrogen Receptor alpha -- drug effects; Estrogen Receptor alpha -- radiation effects; Humans; Selective Estrogen Receptor Modulators -- pharmacology; Tumor Cells, Cultured; Breast cancer; Estrogen receptor; in vitro; Ionizing radiation; info:eu-repo/semantics/article; info:ulb-repo/semantics/articlePeerReview; info:ulb-repo/semantics/openurl/article

Open access content. Open access content

No full-text files
English

EQY oai:dipot.ulb.ac.be:2013/53069
uri/info:doi/10.1007/s10549-005-5148-0
uri/info:pmid/16136271
uri/info:scp/26644435539
764632653

UNIVERSITE LIBRE DE BRUXELLES
From OAIster®, provided by the OCLC Cooperative.

edsoai.ocn764632653